Towards the enzymatic synthesis of phosphorothioate containing LNA oligonucleotides
Graphical abstract
Section snippets
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
We thank Institut Pasteur (starting funds to M.H.) and Roche for financial support. We would like to thank Irene Marzuoli for help with the modelling and docking experiments and Martin Olbrich for help with the manuscript preparation and for fruitful discussions.
References (46)
- et al.
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability
Mol Ther11
(2008) - et al.
Phosphorothioate nucleic acids for probing metal binding, biosensing and nanotechnology
Coord Chem Rev
(2021) - et al.
A multifunctional LNA oligonucleotide-based strategy blocks AR expression and transactivation activity in PCa cells
Mol Ther-Nucl Acids
(2021) - et al.
(S)-5′-C-Aminopropyl-2′-O-methyl nucleosides enhance antisense activity in cultured cells and binding affinity to complementary single-stranded RNA
Bioorg Med Chem
(2021) - et al.
Locked nucleic acid gapmers and conjugates potently silence ADAM33, an asthma-associated metalloprotease with nuclear-localized mRNA
Mol Ther Nucleic Acids
(2017) - et al.
Smart conferring of nuclease resistance to DNA by 3′-end protection using 2′,4′-bridged nucleoside-5′-triphosphates
Bioorg Med Chem Lett
(2009) - et al.
Enzymatic polymerisation involving 2′-amino-LNA nucleotides
Bioorg Med Chem Lett
(2012) - et al.
Polymerase-directed synthesis of C5-ethynyl locked nucleic acids
Bioorg Med Chem Lett
(2010) - et al.
Structures of Intermediates along the catalytic cycle of terminal deoxynucleotidyltransferase: dynamical aspects of the two-metal ion mechanism
J Mol Biol
(2013) - et al.
Effect of P-chirality of oligo(deoxyribonucleoside phosphorothioate)s on the activity of terminal deoxyribonucleotidyl transferase
FEBS Lett
(1998)
Compatibility of 5-ethynyl-2' F-ANA UTP with in vitro selection for the generation of base-modified, nuclease resistant aptamers
Org Biomol Chem
(2019)
Modified nucleoside triphosphates in bacterial research for in vitro and live-cell applications
RSC Chem Biol
(2020)
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
N Engl J Med
(2020)
Advances in oligonucleotide drug delivery
Nat Rev Drug Discov
(2020)
Recent progress in non-native nucleic acid modifications
Chem Soc Rev
(2021)
Antisense technology: an overview and prospectus
Nat Rev Drug Discov
(2021)
In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3 ' and 5' thiophosphate linkages
Nucleic Acids Res
(2020)
Unlocking P(V): reagents for chiral phosphorothioate synthesis
Science
(2018)
Locked vs. unlocked nucleic acids (LNAvs.UNA): contrasting structures work towards common therapeutic goals
Chem Soc Rev
(2011)
Locked nucleic acid: A potent nucleic acid analog in therapeutics and biotechnology
Oligonucleotides
(2004)
Systemic evaluation of chimeric LNA/2' OMe steric blockers for myotonic dystrophy type 1 therapy
Nucl Acid Ther
(2020)
Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
Nucleic Acids Res
(2016)
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Nat Biotechnol
(2019)
Cited by (0)
© 2021 Elsevier Ltd. All rights reserved.